Twitxy Saved

Paul Studenic

@Stiddyo

MD PhD│ Clinician in Internal Medicine and Rheumatology │ Clinical and translational Researcher │ @ARD_BMJ │ @oegrr │ @EULAR_JC
Joined November 2010
592 Following 1.3K Followers 1.9K Posts

Latest posts 5

Paul Studenic @Stiddyo
First publication of @Golnaz_shams95 PhD project together with the @STRATA_FIT consortium.

Really proud to see the effort summarised in this publication! 👌

It sets another starting point for integrating evidence in the clinical decisions to face with patients and #D2T #RA
RMD Open Verified account @bmj_rmdopen Aug 13
Updated systematic literature review of D2T #RA

✅ 8,589 records screened, 131 studies included
✅ JAK inhibitors showed efficacy after ≥2 prior bDMARD failures
⚠️ Safety needs careful risk stratification, especially infection, malignancy and CV risk.
❌ Evidence for non-pharmacological strategies remains very limited.

🔓 rmdopen.bmj.com/content/12/3/e…
View quoted post on X
Paul Studenic @Stiddyo
Proud to see the #first article of my PhD student Nasim Nakhost Lotfi published. 😊👏👏

Our work based on our collaborative project done in the #cotidiana consortium, coordinated by Francisco Nunes from @FhP_AICOS
#rheum
#RA
#sjoegren
RMD Open Verified account @bmj_rmdopen Jul 4, 2025
📱 Reliable daily ePROMs via COTIDIANA app

📝 48 pts (PsA, SjD, OA) logged VAS for pain, fatigue, sleep, mood, PGA

 ✅ 1–3-day test-retest ➡️ intraclass correlation coefficients ≥ 0.83

 ✅ ≥4-day intervals → reliability drops (ICC 0.23–0.73)


💡 Supports personalised, low-burden remote monitoring across RMDs

@Stiddyo

🔓rmdopen.bmj.com/content/11/2/e…
View quoted post on X